| Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel D Mevorach, E Anis, N Cedar, M Bromberg, EJ Haas, E Nadir, ... New England Journal of Medicine 385 (23), 2140-2149, 2021 | 594 | 2021 |
| Haptoglobin: basic and clinical aspects AP Levy, R Asleh, S Blum, NS Levy, R Miller-Lotan, S Kalet-Litman, ... Antioxidants & redox signaling 12 (2), 293-304, 2010 | 333 | 2010 |
| Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease R Asleh, S Marsh, M Shilkrut, O Binah, J Guetta, F Lejbkowicz, B Enav, ... Circulation research 92 (11), 1193-1200, 2003 | 314 | 2003 |
| Haptoglobin genotype–and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo R Asleh, J Guetta, S Kalet-Litman, R Miller-Lotan, AP Levy Circulation research 96 (4), 435-441, 2005 | 235 | 2005 |
| Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction M Suleiman, D Aronson, R Asleh, MR Kapeliovich, A Roguin, SR Meisel, ... Diabetes 54 (9), 2802-2806, 2005 | 179 | 2005 |
| Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque … AP Levy, KR Purushothaman, NS Levy, M Purushothaman, M Strauss, ... Circulation research 101 (1), 106-110, 2007 | 164 | 2007 |
| Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype R Asleh, S Blum, S Kalet-Litman, J Alshiek, R Miller-Lotan, R Asaf, ... Diabetes 57 (10), 2794-2800, 2008 | 153 | 2008 |
| Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype S Blum, M Vardi, JB Brown, A Russell, U Milman, C Shapira, NS Levy, ... Pharmacogenomics 11 (5), 675-684, 2010 | 150 | 2010 |
| In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease R Asleh, AP Levy Vascular health and risk management 1 (1), 19-28, 2005 | 131 | 2005 |
| Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo R Asleh, R Miller-Lotan, M Aviram, T Hayek, M Yulish, JE Levy, B Miller, ... Circulation research 99 (12), 1419-1425, 2006 | 98 | 2006 |
| Long-term sirolimus for primary immunosuppression in heart transplant recipients R Asleh, A Briasoulis, WK Kremers, R Adigun, BA Boilson, NL Pereira, ... Journal of the American College of Cardiology 71 (6), 636-650, 2018 | 89 | 2018 |
| Haptoglobin genotype determines myocardial infarct size in diabetic mice S Blum, R Asaf, J Guetta, R Miller-Lotan, R Asleh, R Kremer, NS Levy, ... Journal of the American College of Cardiology 49 (1), 82-87, 2007 | 67 | 2007 |
| Galectin-3 levels and outcomes after myocardial infarction: a population-based study R Asleh, M Enriquez-Sarano, AS Jaffe, SM Manemann, SA Weston, ... Journal of the American College of Cardiology 73 (18), 2286-2295, 2019 | 57 | 2019 |
| Hypothesis—haptoglobin genotype and diabetic nephropathy FM Nakhoul, R Miller-Lotan, H Awaad, R Asleh, AP Levy Nature clinical practice Nephrology 3 (6), 339-344, 2007 | 51 | 2007 |
| Incidence of malignancies in patients treated with sirolimus following heart transplantation R Asleh, AL Clavell, NL Pereira, B Smith, A Briasoulis, H Alnsasra, ... Journal of the American College of Cardiology 73 (21), 2676-2688, 2019 | 43 | 2019 |
| Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype D Farbstein, S Blum, M Pollak, R Asaf, HL Viener, O Lache, R Asleh, ... Atherosclerosis 219 (1), 240-244, 2011 | 43 | 2011 |
| Mechanical circulatory support: principles and applications DL Joyce, LD Joyce Oxford University Press, 2019 | 42 | 2019 |
| Induction immunosuppressive therapy in cardiac transplantation: a systematic review and meta-analysis A Briasoulis, C Inampudi, M Pala, R Asleh, P Alvarez, J Bhama Heart Failure Reviews 23, 641-649, 2018 | 39 | 2018 |
| Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses A Briasoulis, Y Gao, C Inampudi, P Alvarez, R Asleh, E Chrischilles, ... BMC cardiovascular disorders 20, 1-20, 2020 | 37 | 2020 |
| Divergent Effects of α-Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype R Asleh, AP Levy Antioxidants & redox signaling 12 (2), 209-217, 2010 | 37 | 2010 |
Alexandros BriasoulisNational Kapodistrian University of Athens Medical School, University of IowaVerified email at med.uoa.gr
